Trial intelligence / Profile preview

Topical minoxidil plus betamethasone for androgenetic alopecia

IRCT2016031727095N1Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Apr 2016
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3 trial of minoxidil and betamethasone in androgenetic alopecia (AGA), sponsored by Shahid Beheshti University of Medical Sciences. Started Apr 2016; status: completed.

02

Drugs

minoxidilbetamethasone
03

Conditions

androgenetic alopecia (AGA)

Beyond the preview

Go deeper on IRCT2016031727095N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2016031727095N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call